163 related articles for article (PubMed ID: 28632727)
21. Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma.
Li Y; Zhao C; Yu Z; Chen J; She X; Li P; Liu C; Zhang Y; Feng J; Fu H; Wang B; Kuang L; Li L; Lv G; Wu M
Oncotarget; 2016 Oct; 7(42):68585-68596. PubMed ID: 27612424
[TBL] [Abstract][Full Text] [Related]
22. Lycium barbarum polysaccharide attenuates high-fat diet-induced hepatic steatosis by up-regulating SIRT1 expression and deacetylase activity.
Jia L; Li W; Li J; Li Y; Song H; Luan Y; Qi H; Ma L; Lu X; Yang Y
Sci Rep; 2016 Nov; 6():36209. PubMed ID: 27824080
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance and role of LKB1 in gastric cancer.
Jiang S; Chen R; Yu J; Li N; Ke R; Luo L; Zou J; Zhang J; Zhang K; Lu N; Huang D
Mol Med Rep; 2016 Jan; 13(1):249-56. PubMed ID: 26549522
[TBL] [Abstract][Full Text] [Related]
24. miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin.
Tang Q; Yuan Q; Li H; Wang W; Xie G; Zhu K; Li D
Biochem Biophys Res Commun; 2018 Mar; 497(3):827-834. PubMed ID: 29432736
[TBL] [Abstract][Full Text] [Related]
25. SIRT1 suppresses breast cancer growth through downregulation of the Bcl-2 protein.
Kuo SJ; Lin HY; Chien SY; Chen DR
Oncol Rep; 2013 Jul; 30(1):125-30. PubMed ID: 23673452
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
Zhang Y; Duan G; Feng S
Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
[TBL] [Abstract][Full Text] [Related]
27. miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma.
Xu M; Jin H; Xu CX; Sun B; Mao Z; Bi WZ; Wang Y
Oncotarget; 2014 Oct; 5(19):9472-83. PubMed ID: 25344865
[TBL] [Abstract][Full Text] [Related]
28. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma.
Wang Y; Zhang S; Xu Y; Zhang Y; Guan H; Li X; Li Y; Wang Y
Tumour Biol; 2016 Nov; 37(11):15211-15220. PubMed ID: 27683056
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6.
Li Y; Liu J; Liu ZZ; Wei WB
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5117-5125. PubMed ID: 28051259
[TBL] [Abstract][Full Text] [Related]
31. Tris(2-chloroethyl)phosphate-induced cell growth arrest via attenuation of SIRT1-independent PI3K/Akt/mTOR pathway.
Zhang W; Zhang Y; Wang Z; Xu T; Huang C; Yin W; Wang J; Xiong W; Lu W; Zheng H; Yuan J
J Appl Toxicol; 2016 Jul; 36(7):914-24. PubMed ID: 26378621
[TBL] [Abstract][Full Text] [Related]
32. miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.
Xu Z; Wang T
Biochem Biophys Res Commun; 2014 Jun; 449(2):190-5. PubMed ID: 24802407
[TBL] [Abstract][Full Text] [Related]
33. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
34. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
35. MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein.
Zhang H; Guo X; Feng X; Wang T; Hu Z; Que X; Tian Q; Zhu T; Guo G; Huang W; Li X
Oncotarget; 2017 Jan; 8(2):2342-2355. PubMed ID: 27911265
[TBL] [Abstract][Full Text] [Related]
36. MiR-142 acts as a tumor suppressor in osteosarcoma cell lines by targeting Rac1.
Zheng Z; Ding M; Ni J; Song D; Huang J; Wang J
Oncol Rep; 2015 Mar; 33(3):1291-9. PubMed ID: 25530132
[TBL] [Abstract][Full Text] [Related]
37. miR-130b targets NKD2 and regulates the Wnt signaling to promote proliferation and inhibit apoptosis in osteosarcoma cells.
Li Z; Li Y; Wang N; Yang L; Zhao W; Zeng X
Biochem Biophys Res Commun; 2016 Mar; 471(4):479-85. PubMed ID: 26902120
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-635 inhibits the malignancy of osteosarcoma by inducing apoptosis.
Tian L; Guo Z; Wang H; Liu X
Mol Med Rep; 2017 Oct; 16(4):4829-4834. PubMed ID: 28765920
[TBL] [Abstract][Full Text] [Related]
39. Decreased Expression of miR-548c-3p in Osteosarcoma Contributes to Cell Proliferation Via Targeting ITGAV.
Luo Z; Li D; Luo X; Li L; Gu S; Yu L; Ma Y
Cancer Biother Radiopharm; 2016 Jun; 31(5):153-8. PubMed ID: 27310302
[TBL] [Abstract][Full Text] [Related]
40. CBX8 suppresses Sirtinol-induced premature senescence in human breast cancer cells via cooperation with SIRT1.
Lee SH; Um SJ; Kim EJ
Cancer Lett; 2013 Jul; 335(2):397-403. PubMed ID: 23474493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
